Home » Topics » Regulatory » Patents

Patents
RSS

Berlex discloses factor Xa inhibitors

Nov. 1, 1996

cGMP-PDE inhibitors described by Sanofi Winthrop

Nov. 1, 1996

Hoechst claims new antiarrhythmic agents

Nov. 1, 1996

New dual ACE/NEP inhibitors claimed by Bristol-Myers Squibb

Nov. 1, 1996

Ono discloses cGMP-PDE/TxA2 synthase inhibitors

Nov. 1, 1996

New antiallergic agents from Takeda

Nov. 1, 1996

Pfizer describes a new series of CRF antagonists

Nov. 1, 1996

Japanese researchers disclose glutamate antagonists

Nov. 1, 1996

Meiji Seika discloses compounds that enhance axonal regeneration

Nov. 1, 1996

N-type calcium channel blockers from Sankyo

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...